Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
A NEW PET LIGAND FOR THE DOPAMINE TRANSPORTER - STUDIES IN THE HUMAN BRAIN
Autore:
VOLKOW ND; DING YS; FOWLER JS; WANG GJ; LOGAN J; GATLEY SJ; SCHLYER DJ; PAPPAS N;
Indirizzi:
BROOKHAVEN NATL LAB,DEPT MED,BLDG 490 UPTON NY 11973 SUNY STONY BROOK,DEPT PSYCHIAT STONY BROOK NY 11794
Titolo Testata:
The Journal of nuclear medicine
fascicolo: 12, volume: 36, anno: 1995,
pagine: 2162 - 2168
SICI:
0161-5505(1995)36:12<2162:ANPLFT>2.0.ZU;2-Q
Fonte:
ISI
Lingua:
ENG
Soggetto:
POSITRON EMISSION TOMOGRAPHY; COCAINE BINDING-SITES; PARKINSONS-DISEASE; RECEPTOR-BINDING; INVIVO; BABOON; DRUGS; SYSTEM; ANALOG;
Keywords:
CARBON-11-D-THREO-METHYLPHENIDATE; DOPAMINE TRANSPORTER; COCAINE; DOPAMINE NEURONS;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
55
Recensione:
Indirizzi per estratti:
Citazione:
N.D. Volkow et al., "A NEW PET LIGAND FOR THE DOPAMINE TRANSPORTER - STUDIES IN THE HUMAN BRAIN", The Journal of nuclear medicine, 36(12), 1995, pp. 2162-2168

Abstract

Carbon-11-d-threo-methylphenidate, the active enantiomer of methylphenidate (ritalin), has been shown to bind uniquely to the dopamine transporter in the baboon brain. This study characterizes its binding in the human brain and measures its test-retest reproducibility. Methods: Studies were done in seven normal controls, each of whom was scanned with [C-11]d-threo-methylphenidate on two different occasions. Six subjects were scanned twice 3-5 wk apart without intervention to assess reproducibility. One subject was scanned sequentially before and after treatment with methylphenidate to assess binding saturability. Graphical analysis was used to obtain tissue distribution volumes (DV). The ratio of the DV in the basal ganglia (BG) to that in cerebellum (CB) (DVBG/DVCB), which corresponds to (B-max/Kd) + 1 was used to estimate dopamine transporter availability. Results: Highest tracer uptake occurred in the basal ganglia, where activity peaked 7-11 min postinjection. The half-clearance time for the tracer in brain regions other than thebasal ganglia was 74 min. In the basal ganglia, only 10%-15% of the activity had cleared at 74 min. Time-activity curves for [C-11]d-threo-methylphenidate in the basal ganglia and cerebellum were highly reproducible. The average percent change for the absolute value for DVBG/DVCB was 6.5% +/- 4% (range 0-12%). Methylphenidate pretreatment decreased basal ganglia uptake but not cortical or cerebellar binding and reduced DVBG/DVCB by 62% and B-max/Kd by 91 %. Conclusion: These studies demonstrate that [C-11]d-threo-methylphenidate binding in the human brain is reversible, highly reproducible and saturable. Thus, it is an appropriate PET ligand to measure dopamine transporter availability.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/04/20 alle ore 08:31:23